Journal of Bone Oncology

Papers
(The median citation count of Journal of Bone Oncology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
#15. Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma168
Non-invasive MRI biomarkers for assessment of neoadjuvant chemotherapy response in osteosarcoma: Current techniques and clinical perspectives42
Postoperative outcomes of subaxial cervical spine metastasis: Comparison among the anterior, posterior, and combined approaches33
Real-life use of bone-targeting agents for bone metastases in France between 2009 and 2018: Results of the OPTIMOS study32
Senescence in the bone marrow microenvironment: A driver in development of therapy-related myeloid neoplasms31
MAT2A inhibits the ferroptosis in osteosarcoma progression regulated by miR-26b-5p26
Single Photon Emission Computed Tomography/X-ray Computed Tomography-based radiomics analysis for diagnosis of bone metastases in patients with breast cancer23
Macrophage heterogeneity in bone metastasis23
Lipid metabolic reprogramming and associated ferroptosis in osteosarcoma: From molecular mechanisms to potential targets22
From bimodal to unimodal: The transformed incidence of osteosarcoma in the United States22
Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw21
Demethylzeylasteral inhibits proliferation and metastasis of osteosarcoma cells by modulating the PI3K/AKT/Autophagy pathways21
Predicting lung metastasis in high-grade osteosarcoma: The role of computed tomography angiography (CTA) signs with a focus on vascular wrapping and the intratumoral vascular network20
State-of-the-art of minimally invasive treatments of bone metastases20
Radiomics model based on MRI to differentiate spinal multiple myeloma from metastases: A two-center study20
Preoperative prediction of high-grade osteosarcoma response to neoadjuvant therapy based on a plain CT radiomics model: A dual-center study19
#1. Acid ceramidase (ASAH1) is a key mediator of drug resistance in relapsed/refractory multiple myeloma19
A multicenter, randomized, double-blind trial comparing LY01011, a biosimilar, with denosumab (Xgeva®) in patients with bone metastasis from solid tumors19
Association of androgen receptor and tumour-infiltrating lymphocytes with bone recurrence in triple-negative breast cancer19
Questionable indication for postoperative radiotherapy after surgery for metastases of the major long bones: A single-centre cohort study of 552 fractures/526 patients19
#41. Discovery of novel tubulin code in bone metastasis of breast cancer18
Pain in patients with multiple inherited osteochondromas: Incidence and potential prognostic factors. A retrospective cohort study18
Pathological fractures as an adverse prognostic factor in chondrosarcoma: Results of a systematic review, meta-analysis and institutional case series17
Comprehensive landscape of TGFβ-related signature in osteosarcoma for predicting prognosis, immune characteristics, and therapeutic response17
#23. Elucidating the role of bone marrow stiffness in estrogen signaling in metastatic breast cancer to the bone17
Rotationplasty performed in adults versus minors: a comparative study of long-term quality of life, functional and biomechanical outcomes17
#49. Complete estrogen-deprived athymic nude mice are susceptible to changes in metabolism and musculoskeletal function mediated by a high-fat diet16
#2. Homing of intestinal NK and Th1 cells to the tumor site restrains melanoma bone growth in a gut microbiome dependent manner16
Intraosseous conventional central chondrosarcoma does not metastasise irrespective of grade in pelvis, scapula and in long bone locations16
#6. Mechanical loading of breast cancer laden bones alters osteocyte mediated bone loss in vivo16
Zoledronic acid in metastatic castrate-sensitive prostate cancer: A state-of-the-art review16
#31. A Phase I/II trial of ATI-2231 with Phase Ia in advanced soild tumor malignancies followed by Phase Ib/II in combination with capecitabine in patients with hormone receptor-positive (HR+) and HER16
#14. Determining how prostate cancer cell heterogeneity promotes bone metastasis using fluid-walled microfluidics15
Incidence and radiotherapy treatment patterns of complicated bone metastases15
Long-term oncological and functional outcomes in patients with bone sarcomas in the proximal femur undergoing unplanned surgery: A single-center retrospective cohort study15
Targeting stromal p38MAPKalpha triggers innate-adaptive anti-tumor immunity and sensitizes metastatic breast cancer to immunotherapy14
Impact of myosteatosis on prognosis in multiple myeloma patients: A subgroup analysis of 182 cases and development of a nomogram14
Molecular imaging of bone metastasis14
Reprogramming of glucose metabolism: Metabolic alterations in the progression of osteosarcoma13
From imaging to omics: deep learning is bridging MRI and liquid biopsy in bone tumor diagnosis13
FemurTumorNet: Bone tumor classification in the proximal femur using DenseNet model based on radiographs13
LncRNA SATB2-AS1 promotes tumor growth and metastasis and affects the tumor immune microenvironment in osteosarcoma by regulating SATB213
Immune checkpoint inhibitors in bone metastasis: Clinical challenges, toxicities, and mechanisms13
The roles of the FL/FLT3 axis in the development of cancer-induced bone pain mediated by prostate cancer12
#45. Fatty acid binding proteins may modulate myeloma in Fabp4/5 double knockout mouse11
The impact of comprehensive local therapy on treatment outcomes of non-small cell lung cancer with solitary skeletal oligometastasis11
#51. High dimensional profiling of human prostate metastatic bone marrow microenvironment using mass cytometry11
#50. Investigating the role of EphA2 in breast cancer bone metastasis11
Molecular pathological insights into tumorigenesis and progression of giant cell tumor of bone11
Latest developments in the pathobiology of Ewing sarcoma11
#8. Radium-223 treated primary patient bone biopsy analysis: Macro to microscale analyses and dosimetry11
#7. Downstream effects of Gli2 targeting on tumor-immune cell crosstalk in bone metastatic breast cancer11
YBX1-interacting small RNAs and RUNX2 can be blocked in primary bone cancer using CADD52211
Multicenter study on atypical femoral fractures in patients with bone metastases taking bone- modifying agents11
Mixed reality infrastructure based on deep learning medical image segmentation and 3D visualization for bone tumors using DCU-Net11
Automatic classification of spinal osteosarcoma and giant cell tumor of bone using optimized DenseNet11
COPB2 as a key regulator of cell growth in human osteosarcoma cells: Potential therapeutic target and prognostic indicator10
Treatment of myeloma bone disease: When, how often, and for how long?10
Pexmetinib suppresses osteoclast formation and breast cancer induced osteolysis via P38/STAT3 signal pathway10
Bones and guts – Why the microbiome matters10
Efferocytosis-associated transcriptomic patterns characterize prognosis and immune landscape in osteosarcoma10
Bone metastasis in colorectal cancer: Pathophysiology, prognostic factors, survival outcomes, and treatment strategies – A comprehensive review10
Health- related quality of life after surgery for spinal metastases10
Yin Yang 1 protein-activated N-acetyltransferase 10 drives cell malignant progression of osteosarcoma through ac4C acetylation of integrin β39
Circ_0051079 silencing inhibits the malignant phenotypes of osteosarcoma cells by the TRIM66/Wnt/β-catenin pathway in a miR-625-5p-dependent manner9
Cav3.2 T-Type calcium channels downregulation attenuates bone cancer pain induced by inhibiting IGF-1/HIF-1α signaling pathway in the rat spinal cord9
Luteolin attenuates the chemoresistance of osteosarcoma through inhibiting the PTN/β-catenin/MDR1 signaling axis by upregulating miR-3849
A novel adjunctive diagnostic method for bone cancer: Osteosarcoma cell segmentation based on Twin Swin Transformer with multi-scale feature fusion9
Non-POEMS osteosclerotic multiple myeloma: Clinical characteristics and differential diagnosis9
Tenosynovial giant cell tumor of the hip: a systematic review and institutional case series with Meta-analysis of recurrence and patient-reported outcomes9
Does liquid nitrogen recycled autograft for treatment of bone sarcoma impact local recurrence rate? A systematic review9
Dual-target neoadjuvant therapy with denosumab and sunitinib for giant cell tumor of bone: a sarcoma center experience9
Deep hashing and attention mechanism-based image retrieval of osteosarcoma scans for diagnosis of bone cancer9
Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma8
Abaloparatide and paclitaxel combination therapy Improves bone volume and tumor burden in Bone-Metastatic breast cancer8
The metastatic role of the CXCL10-CXCR3 axis and its therapeutic potential in osteosarcoma8
RGS1 stabilized by METTL3-mediated m6A modification promotes the tumorigenicity and macrophage M2 polarization in osteosarcoma8
Radiographic imaging and diagnosis of spinal bone tumors: AlexNet and ResNet for the classification of tumor malignancy8
Surgical Options for Aggressive Vertebral Hemangiomas:A case series, literature review and treatment recommendations8
Multimodal deep learning for bone tumor diagnosis with clinical imaging, pathology, and blood biomarkers8
Feasibility and oncologic outcome of En bloc resection with intentional tumor transgression in primary spinal sarcoma: The Korean Society of Spinal Tumors multicenter study (KSST 2024–02)8
Malignant and metastatic giant cell tumors of bone; clinical course of primary or secondary malignant and pulmonary metastatic variants8
Diagnostic value of H3F3A mutation and clinicopathological features of giant cell tumours in non-long bones8
Groenlandicine enhances cisplatin sensitivity in cisplatin-resistant osteosarcoma cells through the BAX/Bcl-2/Caspase-9/Caspase-3 pathway7
The role of IL-1B in breast cancer bone metastasis7
Diagnosis of newly developed multiple myeloma without bone disease detectable on conventional computed tomography (CT) scan by using dual-energy CT7
Analysis of morbidity and mortality in patients with primary bone tumors who underwent sacrectomy: A systematic review7
An enhanced AlexNet-Based model for femoral bone tumor classification and diagnosis using magnetic resonance imaging7
Determinants of tumor necrosis and its impact on outcome in patients with Localized osteosarcoma uniformly treated with a response adapted regimen without high dose Methotrexate– A retrospective insti7
The 100 most cited papers on bone metastasis: A bibliometric analysis7
#13. 3D printed bioactive glasses porous scaffolds with high strength for the repair of long-bone segmental defects7
Auxiliary diagnosis of primary bone tumors based on Machine learning model7
Chronic kidney disease and denosumab in metastatic bone disease: A multicenter Turkish cohort study on severe hypocalcemia, skeletal events, and survival7
Osteofibrous dysplasia, osteofibrous Dysplasia-Like adamantinoma, and adamantinoma: A Single-center retrospective analysis7
Pharmacologic Hedgehog inhibition modulates the cytokine profile of osteolytic breast cancer cells7
Essential genes analysis reveals small ribosomal subunit protein eS28 may be a prognostic factor and potential vulnerability in osteosarcoma6
BMS-794833 reduces anlotinib resistance in osteosarcoma by targeting the VEGFR/Ras/CDK2 pathway6
Social determinants are associated with clinical presentation of acute pathological fracture in metastatic long-bone disease6
AI diagnostics in bone oncology for predicting bone metastasis in lung cancer patients using DenseNet-264 deep learning model and radiomics6
Optimal timing for local ablative treatment of bone oligometastases in non-small cell lung cancer6
Differential expression of CD74 and C1QB in jaw versus long bone osteosarcoma: Insights from animal models, public datasets and clinical cohorts6
Tyrosine kinase inhibitors in osteosarcoma: Adapting treatment strategiesa6
Management of bone metastasis with zoledronic acid: A systematic review and Bayesian network meta-analysis6
Benign and malignant bone lesion diagnosis based on self-supervised and radiomics fusion using SPECT/CT images6
Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial6
Doxorubicin induces bone loss and modifies multiple cell populations in vivo – Implications for modelling of bone metastasis6
#12. Potential role of bone metastasis-associated fibroblasts in prostate cancer-induced bone pain6
Quality of resection margin with patient specific instrument for bone tumor resection5
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis5
Management of aromatase inhibitor-associated bone loss (AIBL) in women with hormone-sensitive breast cancer: An updated joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG5
CDK4/6 inhibitor and doxorubicin synergistically inhibit breast cancer bone metastasis and enhance T-cell targeted therapy5
Impact of adjuvant imatinib on bone and muscle density in patients with resected gastrointestinal stromal tumors5
Mri-based habitat and peritumoral radiomics for predicting the proliferative activity of stromal cells in giant cell tumor of bone5
Progression of vertebral fractures in metastatic melanoma and non-small cell lung cancer patients given immune checkpoint inhibitors5
Predicting bone metastasis risk of colorectal tumors using radiomics and deep learning ViT model5
#43. Long-chain acyl-CoA synthetases support multiple myeloma cell proliferation, survival and mitochondrial function5
Bone tumor examination based on FCNN-4s and CRF fine segmentation fusion algorithm5
EFEMP1 binds to STEAP1 to promote osteosarcoma proliferation and invasion via the Wnt/β-catenin and TGF-β/Smad2/3 signal pathways5
Development and validation of a biopsy-based model using tumor-associated neutrophils to predict neoadjuvant chemotherapy response in osteosarcoma: a large single-center retrospective cohort study5
Is surgery without curettage effective for periacetabular Metastasis? Insights from a survival study of 93 patients5
#21. PD-1 blockade induces bone loss and reduces bone strength in a breast cancer bone metastasis model5
Emerging roles for stromal cells in bone metastasis5
Metastatic bone disease in proximal femur. Outcome of surgical treatments. − Do we know what to do?4
Therapeutic approaches in patients with bone metastasis due to endometrial carcinoma – A systematic review4
MUTARS® Humero pro Femur replacement: A novel reconstructive procedure after malignant bone tumor resection of the femur in young children4
The phosphatase CTDSPL2 promotes proliferation, invasion, metastasis and regorafenib resistance in osteosarcoma4
Single-cell RNA-seq reveals intratumoral heterogeneity in osteosarcoma patients: A review4
Impact of quantitative CT texture analysis on the outcome of CT-guided bone biopsy4
#35. Defining short-form RON mediated anti-tumor immunity in breast cancer bone metastasis4
Recombinant LGR4 extracellular domain attenuates osteoclastogenesis and prevents bone metastasis via RANKL inhibition4
Modified OPTIModel with oligometastatic disease for the prediction of overall survival of patients with renal cell cancer and symptomatic long bone metastases4
Psychosocial impact of COVID-19 pandemic on patients with solid malignancies and bone metastases (PsyCO-B): a multicentre prospective observational study4
Application of responsive nano-drug carriers in bone tumor chemotherapy4
Bone density measurement in patients with spinal metastatic tumors using chest quantitative CT deep learning model4
CDK4/6 inhibitor ribociclib and doxorubicin combination treatment inhibits breast cancer bone metastasis and enhances T-cell targeted therapy4
Bone-derived excess TGF-ß release is associated with cognitive dysfunction due to oxidation of RyR, Ca2+ leak and mitochondrial dysfunction4
#5. Activating RET mutations in medullary thyroid cancer cells promotes osteoblastic bone metastasis by inhibiting osteoclastogenesis and stimulating osteoblast activity4
Automated measurement of lumbar pedicle screw parameters using deep learning algorithm on preoperative CT scans4
Adipocytes and metabolism: Contributions to multiple myeloma4
Clinically aligned whole-body MRI segmentation of skeletal metastases via Supervised Anatomical Pretraining4
Prevalence of low bone mineral density and risk of fractures in osteosarcoma and Ewing’s sarcoma survivors: A scoping review4
Focal adhesion kinase inhibitors prevent osteoblast mineralization in part due to suppression of Akt-mediated stabilization of osterix4
Analysis of 121 cases of osteosarcoma of jaws reported in the literature over the past two decades: a scoping review4
#3. IL-17A supports osteoblasts to become cancer-associated fibroblasts in breast cancer bone metastases4
Surgical management and outcome of Extra-adrenal myelolipomas at unusual locations: A report of 11 cases in a single center4
#39. Bone-derived Dickkopf-related protein 1 supports primary breast cancer growth and alters hematopoiesis3
Analysis of intercellular communication in the osteosarcoma microenvironment based on single cell sequencing data3
Clinicopathological features and survival disparities between axial and appendicular skeletal Angiosarcoma: A SEER-based analysis using competing risk models3
Exploring bone-tumor interactions through 3D in vitro models: Implications for primary and metastatic cancers3
Epigenetic control of the vicious cycle3
Chondroblastoma of the femoral head:current and future therapeutic options3
#38. Cholesterol increases bone marrow tumour burden in myeloma in vivo and promotes myeloma cell viability and bortezomib resistance ex vivo3
-AI-assisted diagnostic potential of CT in bone oncology and its impact on clinical decision-making for intensive care3
Predicting lung cancer bone metastasis using CT and pathological imaging with a Swin Transformer model3
Comprehensive analysis of cancer and non-cancer mortality in patients with bone metastases: A population-based study3
Single-cell transcriptional profiling in osteosarcoma and the effect of neoadjuvant chemotherapy on the tumor microenvironment3
Imaging evaluation of blood supply changes after chemotherapy of osteosarcoma and its correlation with tumor necrosis rate3
The METTL3/TGF-β1 signaling axis promotes osteosarcoma progression by inducing MSC differentiation into CAFs via m6A modification3
#24. Mechanical loading-induced changes to the bone microenvironment control bone metastatic breast cancer lesions3
RNA 5-methylcytosine status is associated with DNMT2/TRDMT1 nuclear localization in osteosarcoma cell lines3
Bone cement implantation syndrome in patients with cemented endoprostheses for metastatic bone disease in the femur3
Efficacy of replacing actinomycin-D with carboplatin in Ewing sarcoma consolidation treatment: Single-center experience3
Comprehensive diagnostic model for osteosarcoma classification using CT imaging features3
Soft tissue recurrence in giant cell tumor of Bone: A comprehensive review of pathogenesis, imaging features, and clinical management3
#4. Elucidating the effect of glutamine metabolism in breast-to-bone metastasis3
How has the field of metastatic breast cancer in bones evolved over the past 22 years?2
Reversine inhibits proliferation and induces apoptosis of human osteosarcoma cells through targeting MEK12
Decoding the immune landscape in Ewing sarcoma pathogenesis: The role of tumor infiltrating immune cells and immune milieu2
The validity of the distress thermometer in patients with musculoskeletal tumors2
Pelvic bone tumor segmentation fusion algorithm based on fully convolutional neural network and conditional random field2
hMSCs-derived exosomal MIR17HG promotes follicular helper T cell differentiation and osteosarcoma progression via the miR-372-3p/BCL6 axis2
Outcomes and prognostic factors after surgery for bone metastases in the extremities and pelvis: A retrospective analysis of 140 patients2
Synergistic effect between denosumab and immune checkpoint inhibitors (ICI)? A retrospective study of 268 patients with ICI and bone metastases2
Quantitative preoperative patient assessments are related to survival and procedure outcome for osseous metastases2
Cutting edge developments in bone oncology – Highlights from the Cancer and Bone Society 2024 annual meeting2
Metastatic renal cell carcinoma: risk of rapid progression to pathological fractures and factors influencing post-treatment survival – a Swedish Nationwide cohort study2
#47. Chemotherapy-induced microenvironmental changes promote dormant breast cancer cell growth in the adipose tissue2
Age-related real-world treatment patterns and outcomes of localised, high-grade osteosarcoma2
Lipopolysaccharide-binding protein expression is associated to the metastatic status of osteosarcoma patients2
Assessing the mechanism of osteosarcoma induced by long-term PET exposure: prediction from combined network toxicology, machine learning and molecular docking2
Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer2
#16. Variable fluid stresses may alter breast cancer expression in a 3D perfusion model of bone metastasis2
Naringenin induces ferroptosis in osteosarcoma cells through the STAT3-MGST2 signaling pathway2
Health-related quality of life and physical activity in children with Multiple Osteochondromas2
#29. A novel control mechanism of endosomal trafficking in bone metastatic breast cancer cells2
Surgical margin assessment of bone tumours: A systematic review of current and emerging technologies2
Circular RNA circDOCK1 contributes to osteosarcoma progression by acting as a ceRNA for miR-936 to regulate LEF12
#30. Fractures in metastatic hormone-sensitive prostate cancer (mHSPC). Results from two phase 3 trials from the STAMPEDE platform2
The risk of pathological fractures after intralesional curettage in Atypical Cartilaginous Tumours: A retrospective cohort study2
0.12873291969299